3Biotech (re)opens their blog today ! We will fill this blog weekly with our views on drug development, CMC challenges for small and big molecules, and the congresses we’re attending.

 

3Biotech services

We are specialized in CMC (Chemistry Manufacturing and Control) and pharmaceutical development. We support most of our customers from research to first in man. As an example, we are currently managing those tasks for our clients:

  • Defining, the drug development strategy (Target Product Profile, development plan, preclinical studies …),
  • Screening the most appropriate technological solutions (cell lines, manufacturing processes, analytical methods, Bioassays …),
  • Selecting, worldwide, the most appropriate CRO / CDMOs for the project,
  • Leading and coordinating all stakeholders and ensure timelines, quality and cost
  • Programing and monitoring the production of clinical batches,
  • Writing of IMPD and IND, …

3Biotech track record

Founded in 2011, we now have over 30 projects conducted for 24 clients. 90% of them were biologics and 10% small molecules, targeting diseases such as cancer, stroke, of multiresistant infections. Let’s take a look at our achievements so far:

  • 19 mAbs including one bispecific. 18 months from your lab to the phase 1,
  • 5 therapeutic proteins,
  • 2 vaccines,
  • 2 small molecules,
  • 2 hyperglycosilated proteins,
  • 2 veterinary projects

Needless to say that your drug project, if you have one, is probably in our range of know-how. Contact contact@3biotech.com for more information.